FDA Inspection 1162839 — Guillaume M. Canaud, MD, PhD

Guillaume M. Canaud, MD, PhD — FEI 3020920523

The FDA completed an inspection of Guillaume M. Canaud, MD, PhD on Feb 17, 2022 in Paris. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.